You are here

  • Home
  • Archive
  • Volume 6, Issue 1
  • Early non-response to certolizumab pegol in rheumatoid arthritis predicts failure to achieve low disease activity at 1 year: data from a prospective observational study

Article metrics

Article menu

Download PDFPDF

Rheumatoid arthritis
Original article
Early non-response to certolizumab pegol in rheumatoid arthritis predicts failure to achieve low disease activity at 1 year: data from a prospective observational study

 

Online download statistics by month:

Online download statistics by month: January 2020 to March 2024

AbstractFullPdf
Jan 202023122887
Feb 2020807236
Mar 2020414117
Apr 20201019920
May 2020414115
Jun 202011511412
Jul 202029278
Aug 202043425
Sep 202050439
Oct 2020373510
Nov 202031288
Dec 202028283
Jan 202122226
Feb 202128265
Mar 2021292713
Apr 2021151510
May 2021232126
Jun 202133326
Jul 202124245
Aug 2021171611
Sep 202122216
Oct 2021313218
Nov 2021262324
Dec 202116145
Jan 202215154
Feb 202231303
Mar 2022282710
Apr 202215144
May 2022363726
Jun 202228274
Jul 202243413
Aug 202244475
Sep 2022606011
Oct 2022424213
Nov 202237376
Dec 2022394014
Jan 202372726
Feb 202342424
Mar 202315164
Apr 202321195
May 202312125
Jun 202313132
Jul 202314146
Aug 2023884
Sep 202313132
Oct 202328279
Nov 202319193
Dec 202319192
Jan 202412122
Feb 202416168
Mar 2024181896
Total18531808626